Adalimumab biosimilar (Momenta Pharmaceuticals)
阿达木单抗生物类似药（Momenta Pharmaceuticals）
Report date: 2022/07/19 20:00:45
Base Information
Drug NameAdalimumab biosimilar (Momenta Pharmaceuticals)
Drug Alias Name +[8]
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory +[10]
CombinationsNo
Global Highest StatusPending (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesMomenta
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesBaxalta IncorporatedMomenta Pharmaceuticals Inc
Active IndicationsN/A
Inactive Indications
Other Information
ATC Code
Related LinksN/A